ACRS logo

Aclaris Therapeutics (ACRS) Free Cash Flow

Annual FCF

-$79.63 M
-$11.46 M-16.81%

December 31, 2023

Summary

Performance

1-Year Change

-16.81%

3-Year Change

-103.74%

5-Year Change

+22.06%

15-Year Change

-42.46%

ACRS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.77%
ACRS annual free cash flow is higher than 19.77% of companies in Healthcare sector

High & Low

All-time High

-$4.92 M

3-Year Low

-$79.63 M
ACRS annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACRS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
ACRS next annual earnings announcement is scheduled for Feb 27, 2025

OtherACRScash flowmetrics:

Annual CFO

-$78.33 M
ACRS annual cash flow from operations is -$78.33 million

Annual CFF

$26.71 M
ACRS annual cash flow from financing activities is $26.71 million

Annual CFI

$46.22 M
ACRS annual cash flow from investing activities is $46.22 million

Annual CAPEX

$1.31 M
ACRS annual capital expenditures is $1.31 million

Quarterly FCF

$22.00 M
+$34.31 M+278.75%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+189.28%

3-Year Change

+306.34%

5-Year Change

+190.98%

ACRS Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.31%
ACRS quarterly free cash flow is higher than 87.31% of companies in Healthcare sector

High & Low

All-time High

$22.00 M
ACRS quarterly free cash flow is currently at an all-time high

3-Year Low

-$26.91 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
ACRS next earnings announcement is scheduled for Feb 27, 2025

OtherACRScash flowmetrics:

Quarterly CFO

$22.00 M
ACRS quarterly cash flow from operations is $22.00 million

Quarterly CFF

$22.00 K
ACRS quarterly cash flow from financing activities is $22.00 thousand

Quarterly CFI

$2.79 M
ACRS quarterly cash flow from investing activities is $2.79 million

Quarterly CAPEX

$0.00
ACRS quarterly capital expenditures is $0.00

TTM FCF

-$18.46 M
+$46.64 M+71.64%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+79.86%

3-Year Change

+58.08%

5-Year Change

+74.84%

ACRS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.43%
ACRS TTM free cash flow is higher than 49.43% of companies in Healthcare sector

High & Low

All-time High

-$2.88 M

3-Year Low

-$91.65 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
ACRS next earnings announcement is scheduled for Feb 27, 2025

OtherACRScash flowmetrics:

TTM CFO

-$17.90 M
ACRS TTM cash flow from operations is -$17.90 million

TTM CFF

$5000.00
ACRS TTM cash flow from financing activities is $5000.00

TTM CFI

$26.50 M
ACRS TTM cash flow from investing activities is $26.50 million

TTM CAPEX

$562.00 K
ACRS TTM capital expenditures is $562.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$79.63 M
ACRS annual free cash flow is -$79.63 million

Annual CFO

-$78.33 M
ACRS annual cash flow from operations is -$78.33 million

Annual CAPEX

$1.31 M
ACRS annual capital expenditures is $1.31 million

ACRS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.8%+189.3%+79.9%
3 y3 years-103.7%+306.3%+58.1%
5 y5 years+22.1%+191.0%+74.8%

ACRS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-51.9%at lowat high+181.8%at high+79.9%
5 y5-year-103.7%+18.8%at high+181.8%at high+81.2%
alltimeall time-1518.6%+22.1%at high+169.6%-541.2%+83.5%

Aclaris Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
$22.00 M(-278.7%)
-$18.46 M(-71.6%)
Jun 2024
-
-$12.31 M(-41.3%)
-$65.10 M(-11.6%)
Mar 2024
-
-$20.95 M(+190.9%)
-$73.68 M(-7.5%)
Dec 2023
-$79.63 M(+16.8%)
-$7.20 M(-70.8%)
-$79.63 M(-13.1%)
Sep 2023
-
-$24.64 M(+18.0%)
-$91.65 M(+22.2%)
Jun 2023
-
-$20.89 M(-22.4%)
-$74.98 M(+1.4%)
Mar 2023
-
-$26.91 M(+40.0%)
-$73.94 M(+8.5%)
Dec 2022
-$68.17 M(+30.0%)
-$19.22 M(+141.2%)
-$68.17 M(+2.9%)
Sep 2022
-
-$7.97 M(-59.9%)
-$66.23 M(-3.9%)
Jun 2022
-
-$19.85 M(-6.1%)
-$68.92 M(+12.4%)
Mar 2022
-
-$21.13 M(+22.3%)
-$61.34 M(+17.0%)
Dec 2021
-$52.44 M(+34.2%)
-$17.27 M(+62.0%)
-$52.44 M(+19.1%)
Sep 2021
-
-$10.66 M(-13.1%)
-$44.03 M(-3.9%)
Jun 2021
-
-$12.27 M(+0.3%)
-$45.82 M(+3.2%)
Mar 2021
-
-$12.23 M(+38.0%)
-$44.39 M(+13.6%)
Dec 2020
-$39.09 M(-60.1%)
-$8.87 M(-28.8%)
-$39.09 M(-23.2%)
Sep 2020
-
-$12.45 M(+14.9%)
-$50.88 M(-18.7%)
Jun 2020
-
-$10.84 M(+56.4%)
-$62.60 M(-14.7%)
Mar 2020
-
-$6.93 M(-66.5%)
-$73.39 M(-25.2%)
Dec 2019
-$98.06 M
-$20.66 M(-14.6%)
-$98.06 M(-6.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$24.18 M(+11.9%)
-$104.80 M(-5.6%)
Jun 2019
-
-$21.62 M(-31.6%)
-$111.03 M(-0.5%)
Mar 2019
-
-$31.60 M(+15.4%)
-$111.60 M(+9.2%)
Dec 2018
-$102.17 M(+82.8%)
-$27.39 M(-9.9%)
-$102.17 M(+9.2%)
Sep 2018
-
-$30.42 M(+37.1%)
-$93.56 M(+21.3%)
Jun 2018
-
-$22.18 M(+0.1%)
-$77.13 M(+18.3%)
Mar 2018
-
-$22.17 M(+18.0%)
-$65.21 M(+16.7%)
Dec 2017
-$55.90 M(+60.5%)
-$18.79 M(+34.3%)
-$55.90 M(+23.5%)
Sep 2017
-
-$13.98 M(+36.1%)
-$45.24 M(+9.7%)
Jun 2017
-
-$10.27 M(-20.1%)
-$41.23 M(+1.2%)
Mar 2017
-
-$12.85 M(+58.0%)
-$40.76 M(+17.0%)
Dec 2016
-$34.84 M(+66.9%)
-$8.13 M(-18.4%)
-$34.84 M(+12.5%)
Sep 2016
-
-$9.97 M(+1.7%)
-$30.97 M(-2.3%)
Jun 2016
-
-$9.80 M(+41.3%)
-$31.70 M(+27.2%)
Mar 2016
-
-$6.93 M(+62.4%)
-$24.93 M(+19.4%)
Dec 2015
-$20.88 M(+159.2%)
-$4.27 M(-60.1%)
-$20.88 M(+25.7%)
Sep 2015
-
-$10.70 M(+253.5%)
-$16.61 M(+181.2%)
Jun 2015
-
-$3.03 M(+5.1%)
-$5.91 M(+105.1%)
Mar 2015
-
-$2.88 M
-$2.88 M
Dec 2014
-$8.05 M(+63.7%)
-
-
Dec 2013
-$4.92 M
-
-

FAQ

  • What is Aclaris Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Aclaris Therapeutics?
  • What is Aclaris Therapeutics annual FCF year-on-year change?
  • What is Aclaris Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Aclaris Therapeutics?
  • What is Aclaris Therapeutics quarterly FCF year-on-year change?
  • What is Aclaris Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Aclaris Therapeutics?
  • What is Aclaris Therapeutics TTM FCF year-on-year change?

What is Aclaris Therapeutics annual free cash flow?

The current annual FCF of ACRS is -$79.63 M

What is the all time high annual FCF for Aclaris Therapeutics?

Aclaris Therapeutics all-time high annual free cash flow is -$4.92 M

What is Aclaris Therapeutics annual FCF year-on-year change?

Over the past year, ACRS annual free cash flow has changed by -$11.46 M (-16.81%)

What is Aclaris Therapeutics quarterly free cash flow?

The current quarterly FCF of ACRS is $22.00 M

What is the all time high quarterly FCF for Aclaris Therapeutics?

Aclaris Therapeutics all-time high quarterly free cash flow is $22.00 M

What is Aclaris Therapeutics quarterly FCF year-on-year change?

Over the past year, ACRS quarterly free cash flow has changed by +$46.64 M (+189.28%)

What is Aclaris Therapeutics TTM free cash flow?

The current TTM FCF of ACRS is -$18.46 M

What is the all time high TTM FCF for Aclaris Therapeutics?

Aclaris Therapeutics all-time high TTM free cash flow is -$2.88 M

What is Aclaris Therapeutics TTM FCF year-on-year change?

Over the past year, ACRS TTM free cash flow has changed by +$73.19 M (+79.86%)